The Venture Codex Logo

The Venture Codex

Overview

Industrial biotechnology company specializing in engineered enzymes.

Founded

2002

Deals · 12mo

0

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

Biotechnology
Chemical
Sustainability

Investment portfolio

3rounds
NAMEDATESIZE
seqWell
Apr 2022Led
$7 MSeries C
Molecular Assemblies
Nov 2021Led
$10 MSeries B
Molecular Assemblies
Apr 2021Participated
$24 MSeries A
seqWell
Apr 2022Led
$7 MSeries C
Molecular Assemblies
Nov 2021Led
$10 MSeries B
Molecular Assemblies
Apr 2021Participated
$24 MSeries A
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Codexis: 3 funding rounds are recorded in the selected participation categories.All available history.
Codexis: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B10
Series C+10

Monthly Deal Activity

Codexis: 3 deals are recorded across 67 months.All available history.
Codexis: 3 deals are recorded across 67 months. All available history
MonthDeals
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Codexis: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Codexis: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3

Deal Size Distribution

Codexis: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Codexis: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M2
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Codexis: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Codexis: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Codexis: 8 co-investors are shown, with Agilent Technologies sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Codexis: 8 co-investors are shown, with Agilent Technologies sharing 1 recorded deals. All available history
Co-investorShared deals
Agilent Technologies1
Alexandria Venture Investments1
Argonautic Ventures1
BroadOak Capital Partners1
Casdin Capital1
iSelect Fund1
LYFE Capital1
Research Corporation Technologies1

Investment Strategy

Codexis: Led accounts for 67% and participating for 33% of round participation.All available history.
Codexis: Led accounts for 67% and participating for 33% of round participation. All available history
CategoryDeals (count)Share (%)
Led267%
Participating133%
Codexis: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Codexis: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Aaron Hammons

Senior Director of Business Development, Americas

Asli Aras

VP & Head of Corporate Development

Karen Frechou-Armijo

SVP & Head of Human Resources

Kevin Norrett

Chief Operating Officer

Margaret Fitzgerald

Chief Legal & Compliance Officer, General Counsel

Rob Wilson

SVP & General Manager, Performance Enzymes

Stephen Dilly

President, CEO and Board member